New equol supplement for relieving menopausal symptoms: Randomized, placebo-controlled trial of Japanese women

Menopause

Volumn 16, Issue 1, 2009, Pages 141-148

  Ishiwata, Naoko ^a   Melby, Melissa K ^b   Mizuno, Shoichi ^b   Watanabe, Shaw ^b  

^a Atomi University   (Japan)

^b NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

Equol; Isoflavones; Menopausal symptoms; Mood; RCT; Supplement

Indexed keywords

EQUOL; ISOFLAVONE; PLACEBO; ESTRADIOL; FOLLITROPIN; ISOFLAVONE DERIVATIVE; LUTEINIZING HORMONE; PHYTOESTROGEN; PROGESTERONE;

ADULT; ANXIETY; ARTICLE; BLOOD SAMPLING; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG ERUPTION; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MOOD; PHYSICAL EXAMINATION; POSTMENOPAUSE; PREMENOPAUSE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; AFFECT; BLOOD; CHEMISTRY; DIET SUPPLEMENTATION; DRUG EFFECT; MENOPAUSE; MIDDLE AGED; PHYSIOLOGY; SOYBEAN; URINE;

ADULT; AFFECT; ANXIETY; DEPRESSION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; ISOFLAVONES; LUTEINIZING HORMONE; MENOPAUSE; MIDDLE AGED; PHYTOESTROGENS; PLACEBOS; PROGESTERONE; QUESTIONNAIRES; SOYBEANS;

EID: 64049088510     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31818379fa     Document Type: Article

References (39)

1. Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC. Health potential of soy isoflavones for menopausal women. Public Health Nutr 1999;2:489-504.
2. Melby MK. Vasomotor symptom prevalence and language of menopause in Japan. Menopause 2005;12:250-257.
3. Melby MK, Lock M, Kaufert P. Culture and symptom reporting at menopause. Hum Reprod Update 2005;11:495-512.
4. Gold EB, Block G, Crawford S, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. Am J Epidemiol 2004;159:1189-1199.
5. Adlercreutz H, Hamalainen E, Gorbach S, Goldin B. Dietary phytooestrogens and the menopause in Japan [letter; comment]. Lancet 1992;339:1233.
6. Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 2004;291:1610-1620.
7. Nelson HD. Postmenopausal estrogen for treatment of hot flashes: clinical applications. JAMA 2004;291:1621-1625.
8. Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003;290:1729-1738.
9. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
10. Heiss G, Wallace R, Anderson GL, et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 2008;299:1036-1045.
11. Nagata C, Takatsuka N, Kawakami N, Shimizu H. Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am J Epidemiol 2001;153:790-793.
12. Messina M, Hughes C. Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency. J Med Food 2003;6:1-11.
13. Howes LG, Howes JB, Knight DC. Isoflavone therapy for menopausal flushes: a systematic review and meta-analysis. Maturitas 2006;55:203-211.
14. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002;137:805-813.
15. Krebs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004;104:824-836.
16. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr 2002;132:3577-3584.
17. Muthyala RS, Ju YH, Sheng S, et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors α and β. Bioorg Med Chem 2004;12:1559-1567.
18. Possemiers S, Bolca S, Eeckhaut E, Depypere H, Verstraete W. Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: producer phenotyping and relation with intestinal community. FEMS Microbiol Ecol 2007;61:372-383.
19. Wang XL, Kim HJ, Kang SI, Kim SI, Hur HG. Production of phytoestrogen S-equol from daidzein in mixed culture of two anaerobic bacteria. Arch Microbiol 2007;187:155-160.
20. Setchell KD, Brown NM, Desai PB, et al. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 2003;133:1027-1035.
21. Arai Y, Uehara M, Sato Y, et al. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 2000;10:127-135.
22. Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr 2002;132:3168-3171.
23. Setchell KD, Cole SJ. Method of defining equol-producer status and its frequency among vegetarians. J Nutr 2006;136:2188-2193.
24. Peeters PH, Slimani N, van der Schouw YT, et al. Variations in plasma phytoestrogen concentrations in European adults. J Nutr 2007;137:1294-1300.
25. Uchiyama S, Ueno T, Suzuki T. Identification of a newly isolated equol-producing lactic acid bacterium from the human feces [in Japanese]. J Intest Microbiol 2007;21:217-220.
26. Uchiyama S, Ueno T, Masaki K, Shimizu S, Aso T, Shirota T. The cross-sectional study of the relationship between soy isoflavones, equol and the menopausal symptoms in Japanese women [in Japanese]. J Jpn Menopause Soc 2007;15:28-37.
27. Lundh TJ, Pettersson H, Kiessling KH. Liquid chromatographic determination of the estrogens daidzein, formononetin, coumestrol, and equol in bovine blood plasma and urine. J AOAC Int 1988;71:938-941.
28. Japanese Society of Obstetrics and Gynaecology Committee on Reproduction and Endocrinology. Menopausal symptom scale for Japanese women [in Japanese]. J Obstet Gynaecol Res 2001;53:13-14.
29. Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25-31.
30. Yokoyama K, Araki S, Kawakami K, Takeshita T. Reliability and validity assessment of the Japanese version of POMS (Profile of Mood States). Jpn J Public Health 1990;37:913-918.
31. Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K. Hot flushes and other menopausal symptoms in relation to soy product intake in Japanese women. Climacteric 1999;2:6-12.
32. Obermeyer CM. Menopause across cultures: a review of the evidence. Menopause 2000;7:184-192.
33. Melby MK. Factor analysis of climacteric symptoms in Japan. Maturitas 2005;52:205-222.
34. Lock M. Encounters With Aging: Mythologies of Menopause in Japan and North America. Berkeley: University of California Press, 1993.
35. Setchell KD. Soy isoflavones - benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 2001;20:354S-362S; discussion 381S-383S.
36. Watanabe S, Zhuo XG, Melby MK, Ishiwata N, Kimira M. Systematic review of intervention studies using isoflavone supplements and proposal for future studies. In: Sugano M, ed. Soy in Health and Disease Prevention. New York, NY: CRC Press, 2005:87-106.
37. Murkies AL, Lombard C, Strauss BJ, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas 1995;21:189-195.
38. Kurzer MS. Hormonal effects of soy in premenopausal women and men. J Nutr 2002;132:570S-573S.
39. Watanabe S, Otaki N, Uehara M, et al. Pharmacokinetics of an equol supplement in humans. Anti Aging Med 2007;4:57-62.